Vertex Pharmaceuticals, Inc. (VRTX)
436.95
-13.46
(-2.99%)
USD |
NASDAQ |
May 15, 16:00
437.70
+0.75
(+0.17%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Liabilities (Quarterly) : 7.122B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.31B |
| Biogen, Inc. | 10.83B |
| Gilead Sciences, Inc. | 32.85B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Moderna, Inc. | 4.08B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.48B |
| Shareholders Equity (Quarterly) | 19.36B |
| Debt to Equity Ratio | 0.1026 |
| Current Ratio | 3.023 |
| Net Debt Paydown Yield | -0.04% |